Skip to main content Skip to main navigation menu Skip to site footer

Effectivity of glutathione and curcumin in hepatic fibrosis induced by cholestasis in Wistar rats

  • Rodijaya Putra ,
  • Adeodatus Yuda Handaya ,
  • Agus Barmawi ,


Background: Cholestasis occurs from the accumulation of bile product in the biliary tract due to obstruction of the hepatobiliary tract. Without early interventions, this condition will be continuing as chronic hepatic injury and form hepatic fibrosis, ending in cirrhosis. Glutathione (GSH) and curcumin were known as antioxidants and anti-inflammatory used as a therapeutic agent for the treatment of hepatopathy. This study aims to determine the effectivity of GSH and curcumin in the hepatic fibrosis mechanism induced by cholestasis.

Methods: This is an experimental study using Wistar rats. They are divided into three groups of 5 rats each. All the rats regard the choledochus duct ligation surgery, rats without intervention define as first group (control), other rats treated with GSH as the second group and the third group consist of rats treated with curcumin. Data were analyzed using SPSS version 17 for Windows.

Results: There was liver injury and hepatic fibrosis induced by cholestasis from this study. This condition was significantly lower in groups treated with GSH and curcumin (p<0.05). Therefore, there was a different result between GSH and curcumin in reducing the process of liver injury and hepatic fibrosis, but the difference was not statistically significant (p>0.05).

Conclusion: GSH and curcumin were statistically effective in reducing liver injury and hepatic fibrosis induced by cholestasis. Despite, there were no significant difference results between them in reducing liver injury and hepatic fibrosis.


  1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-218.
  2. Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193(3):225-231.
  3. Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-S53.
  4. Cederbaum AI. Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury. World J Gastroenterol. 2010;16(11):1366-1376.
  5. Hirota M, Sugi K, Inoue M. Dynamic aspects of glutathione metabolism in obstructive jaundice. J Gastroenterol. 1994;29(5):588-592.
  6. Panozzo MP, Basso D, Balint L, Biasin MR, Bonvicini P, Metus P, et al. Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis. Clin Exp Pharmacol Physiol. 1995;22(4):266-271.
  7. Chen J, Wu F, Long Y, Yu W. Glutathione Supplementation Attenuates Oxidative Stress and Improves Vascular Hyporesponsiveness in Experimental Obstructive Jaundice. Oxid Med Cell Longev. 2015;2015:486148.
  8. Eshaghian A, Khodarahmi A, Safari F, Binesh F, Moradi A. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats. Br J Nutr. 2018;120(4):393-403.
  9. El Swefy S, Hasan RA, Ibrahim A, Mahmoud MF. Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(1):103-116.
  10. Ghoreshi ZA, Kabirifar R, Safari F, Karimollah A, Moradi A, Eskandari-Nasab E. Hepatoprotective effects of curcumin in rats after bile duct ligation via downregulation of Rac1 and NOX1. Nutrition. 2017;36:72-78.
  11. Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 2013;6(1):1-24.
  12. Turk O, Badak B, Ates E, Dundar E, Sutken E. The role of growth factors on hepatic damage in rats with obstructive jaundice. Springerplus. 2016;5(1):1274.
  13. Li S, Tan HY, Wang N, et al. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int J Mol Sci. 2015;16(11):26087-26124.
  14. Cabrera-Rubio R, Patterson AM, Cotter PD, Beraza N. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice. Sci Rep. 2019;9(1):12324.
  15. Tag CG, Sauer-Lehnen S, Weiskirchen S, et al. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp. 2015;(96):52438.
  16. Wang ME, Chen YC, Chen IS, Hsieh SC, Chen SS, Chiu CH. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J Nutr Biochem. 2012;23(10):1352-1366.
  17. Weiskirchen R, Tacke F. Liver fibrosis: Which mechanisms matter?. Clin Liver Dis (Hoboken). 2016;8(4):94-99.
  18. Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, et al. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients. 2018;10(7):855.
  19. Zhang S, Li TS, Soyama A, Tanaka T, Yan C, Sakai Y, et al. Up-regulated extracellular matrix components and inflammatory chemokines may impair the regeneration of cholestatic liver. Sci Rep. 2016;6:26540.
  20. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53(1):209-218.
  21. Purnamaningsih SM. The serum Arginase-1 correlation to child-pugh scores in predicting the severity of cirrhosis. Bali Medical Journal. 2017;6(3):611-615.

How to Cite

Putra, R., Handaya, A. Y., & Barmawi, A. (2021). Effectivity of glutathione and curcumin in hepatic fibrosis induced by cholestasis in Wistar rats. Intisari Sains Medis, 12(2), 459–462.




Search Panel